A phase i trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors

Kyle Holen, Robert DiPaola, Glenn Liu, Antoinette R. Tan, George Wilding, Karl Hsu, Nancy Agrawal, Cong Chen, Lingling Xue, Elizabeth Rosenberg, Mark Stein

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'A phase i trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science